José Baselga

Memorial Sloan-Kettering Cancer Center, New York City, New York, United States

Are you José Baselga?

Claim your profile

Publications (255)3642.27 Total impact

Publication Stats

32k Citations
3,642.27 Total Impact Points

Institutions

  • 1994–2014
    • Memorial Sloan-Kettering Cancer Center
      • • Department of Medicine
      • • Division of Molecular Pharmacology & Chemistry
      New York City, New York, United States
  • 2013
    • Duke University Medical Center
      Durham, North Carolina, United States
    • Weill Cornell Medical College
      New York City, New York, United States
    • The Washington Institute
      Washington, Washington, D.C., United States
    • Unicancer
      Lutetia Parisorum, Île-de-France, France
    • IEO - Istituto Europeo di Oncologia
      Milano, Lombardy, Italy
  • 2012–2013
    • Université Libre de Bruxelles
      • Bordet Institute
      Brussels, BRU, Belgium
    • University of Valencia
      Valenza, Valencia, Spain
    • Institut Marqués, Spain, Barcelona
      Barcino, Catalonia, Spain
  • 2011–2013
    • Dana-Farber Cancer Institute
      • Department of Medical Oncology
      Boston, Massachusetts, United States
    • Massachusetts General Hospital
      Boston, Massachusetts, United States
    • Sarah Cannon Research Institute
      Nashville, Tennessee, United States
    • Hospital Universitario Virgen del Rocío
      Hispalis, Andalusia, Spain
  • 2010–2013
    • University of Barcelona
      • Department of Statistics
      Barcelona, Catalonia, Spain
    • Novartis Institutes for BioMedical Research
      Cambridge, Massachusetts, United States
    • Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
      Milano, Lombardy, Italy
  • 2005–2013
    • Autonomous University of Barcelona
      • Department of Biochemistry and Molecular Biology
      Cerdanyola del Vallès, Catalonia, Spain
    • Indiana University-Purdue University Indianapolis
      Indianapolis, Indiana, United States
  • 2001–2013
    • Vall d’Hebron Institute of Oncology
      Barcino, Catalonia, Spain
    • University of California, Los Angeles
      • Division of Hematology and Medical Oncology
      Los Angeles, CA, United States
  • 2011–2012
    • Harvard Medical School
      Boston, Massachusetts, United States
  • 2010–2012
    • Broad Institute of MIT and Harvard
      • Cancer Program
      Cambridge, Massachusetts, United States
  • 2002–2012
    • Vanderbilt University
      • • Vanderbilt-Ingram Cancer Center (VICC)
      • • Department of Medicine
      Nashville, MI, United States
    • The Portland Hospital
      Londinium, England, United Kingdom
  • 1997–2012
    • University Hospital Vall d'Hebron
      • Department of Medical Oncology
      Barcino, Catalonia, Spain
  • 2008
    • Carl Gustav Carus-Institut
      Pforzheim, Baden-Württemberg, Germany
    • University of Antwerp
      Antwerpen, Flanders, Belgium
  • 2007
    • Universitair Ziekenhuis Antwerpen
      Antwerpen, Flanders, Belgium
  • 2006
    • VHIR Vall d’Hebron Research Institute
      Barcino, Catalonia, Spain
  • 2001–2005
    • University of Texas MD Anderson Cancer Center
      Houston, Texas, United States
  • 2004
    • University Hospital Essen
      Essen, North Rhine-Westphalia, Germany
  • 2003
    • Kinki University
      • Department of Internal Medicine
      Ōsaka, Ōsaka, Japan
    • Karmanos Cancer Institute
      Detroit, Michigan, United States
    • Istituto Nazionale Tumori "Fondazione Pascale"
      Napoli, Campania, Italy